Details for New Drug Application (NDA): 061633
✉ Email this page to a colleague
NDA 061633 describes ROBIMYCIN, which is a drug marketed by Robins Ah and is included in one NDA. Additional details are available on the ROBIMYCIN profile page.
The generic ingredient in ROBIMYCIN is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
The generic ingredient in ROBIMYCIN is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 061633
| Tradename: | ROBIMYCIN |
| Applicant: | Robins Ah |
| Ingredient: | erythromycin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 061633
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
